190 likes | 336 Views
Slide 2 of 19. Drug Abuse Reporting Program. First National Evaluation of Treatment Effectiveness. DARP. Funded by the National Institute on Drug Abuse. Sells, Simpson, Demaree,
E N D
1. Slide 1 of 19 National Treatment Retention Findings from DATOS Charts Prepared & Released for Public Use by
Dwayne Simpson (TCU), Robert Hubbard (NDRI-NC), Douglas Anglin (UCLA), & Bennett Fletcher (NIDA)
2. Slide 2 of 19 Drug Abuse Reporting Program
3. Slide 3 of 19 Daily Opioid Use: % in Year 1 After Discharge
4. Slide 4 of 19 Treatment Outcome Prospective Study
5. Slide 5 of 19 “Treatment Process” in TOPS Comparisons between 21 MM programs
Programs with Longer Retention had -
Better assessment & program planning
Higher MM dose & better UA monitoring
Comprehensive (“wrap-around”) services
Higher patient ratings for “meeting needs”
6. Slide 6 of 19 Drug Abuse Treatment Outcome Studies
7. Slide 7 of 19 Long-Term Residential (LTR)Treatment Changes from Before to After Treatment
8. Slide 8 of 19 Outpatient Drug-Free (ODF) Treatment Changes from Before to After Treatment
9. Slide 9 of 19 Outpatient Methadone Treatment (OMT) Changes from Before to After Treatment
10. Slide 10 of 19 Average Expected vs Observed Length of Stay by Patients (in months)
11. Slide 11 of 19 Patient Retention Rates for Programs(beyond minimum “thresholds”)
12. Slide 12 of 19 Program Retention Rates in LTR(for 90 days or longer)
13. Slide 13 of 19 Program Retention Rates in ODF(for 90 days or longer)
14. Slide 14 of 19 Program Retention Rates in OMT(for 360 days or longer)
15. Slide 15 of 19 Retention Predicts Outcomes Findings Consistent from National Studies
1970s (44,000 admissions in DARP)
1980s (11,000 admissions in TOPS)
1990s (10,000 admissions in DATOS)
Also in England’s NTORS !
Conclusions from Major Reviews
Institute of Medicine (Gerstein & Harwood, ‘90)
16. Slide 16 of 19 Comparison of Year 1 Outcomes by Length of Stay in LTR
17. Slide 17 of 19 DATOS Programs with Lower Retention had more “troubled” caseloads! Admissions to these programs had -
More cocaine & alcohol problems
More previous treatments
More psychological problems
18. Slide 18 of 19 Patient Problems in LTR Programs
19. Slide 19 of 19
20. Slide 20 of 19 Slide Navigator Overview of Treatment Retention Findings from DATOS (title slide)
DARP: Drug Abuse Reporting Program
Daily Opioid Use: % in Year 1 after discharge
TOPS: Treatment Outcome Prospective Study
“Treatment Process” in TOPS
DATOS: Drug Abuse Treatment Outcome Studies
Long-Term Residential (LTR) Treatment: Changes from Before to After Treatment
Outpatient Drug-Free (ODF) Treatment: Changes from Before to After Treatment
Outpatient Methadone Treatment (OMT): Changes from Before to After Treatment
Average Expected vs Observed Length of stay by Patients (in months)
Patient Retention Rates for Programs (beyond minimum “thresholds”)
Program Retention Rates in LTR (for 90 days or longer)
Program Retention Rates in ODF (for 90 days or longer)
Program Retention Rates in OMT (for 360 days or longer)
Retention Predicts Outcomes
Comparison of Year 1 Outcomes by Length of Stay in LTR
DATOS Programs with Lower Retention had more “troubled” caseloads!
Patient Problems in LTR Programs
Slide for DATOS Web site (www.datos.org)